Investors wary of Teva-Mylan merger
April 21, 2015 at 12:36 PM EDT
Investors were wary of Teva Pharmaceuticals’ plan to purchase Mylan N.V., and failed to drive up Mylan share to Teva’s bid price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.